Insider Transactions in Q1 2024 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,790
-5.52%
|
$153,950
$5.31 P/Share
|
|
Mar 12
2024
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
87,720
+13.58%
|
-
|
|
Mar 03
2024
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,023
-3.82%
|
$180,115
$5.47 P/Share
|
|
Mar 03
2024
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
102,629
+9.81%
|
-
|
|
Mar 03
2024
|
Jason B. Daly SVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,030
-17.62%
|
$90,150
$5.47 P/Share
|
|
Mar 03
2024
|
Jason B. Daly SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,871
+36.9%
|
-
|
|
Mar 03
2024
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
44,562
-6.74%
|
$222,810
$5.47 P/Share
|
|
Mar 03
2024
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
88,945
+11.86%
|
-
|
|
Mar 03
2024
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
41,135
-5.12%
|
$205,675
$5.47 P/Share
|
|
Mar 03
2024
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
82,103
+9.26%
|
-
|
|
Mar 01
2024
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,257
-3.18%
|
$66,285
$5.47 P/Share
|
|
Mar 01
2024
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,197
+7.99%
|
-
|
|
Mar 01
2024
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,219
-5.57%
|
$81,095
$5.47 P/Share
|
|
Mar 01
2024
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,371
+9.72%
|
-
|
|
Mar 01
2024
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
15,181
-4.15%
|
$75,905
$5.47 P/Share
|
|
Mar 01
2024
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,957
+7.33%
|
-
|
|
Feb 27
2024
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,670
-5.25%
|
$93,350
$5.71 P/Share
|
|
Feb 27
2024
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,620
+9.11%
|
-
|
|
Feb 27
2024
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,556
-5.99%
|
$82,780
$5.71 P/Share
|
|
Feb 27
2024
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,663
+10.28%
|
-
|
|
Jan 01
2024
|
Gautam Patel Director |
BUY
Bona fide gift
|
Direct |
1,598,115
+44.76%
|
-
|
|
Jan 01
2024
|
Gautam Patel Director |
SELL
Other acquisition or disposition
|
Direct |
33,458,067
-98.89%
|
-
|